U.S. Physical Therapy, Inc. USPH NYSE · Healthcare · United States
$99.76 +1.18% +$1.16
Summary
45 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 14 years in a row.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share fell by 25% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 3.8 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 10.0%. Earnings per share fell by 25% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $2.23M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.86%
- Raised in a row
- 14 years
You receive $1.83 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 10
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $90 is 9.8% below today's price. 77% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Net Patient Revenues 83%
- Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues 17%
By region
The company reports no revenue by region.
Net Patient Revenues brings in 83% of revenue. Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues grew fastest, by 20% a year.
Segments in detail